Parker Waichman LLP

Some Type 2 Diabetes Drugs Associated with Pancreatitis, Pancreatic Cancer

Some Type 2 diabetes drugs are being associated with potential increased risks for pancreatitis and pancreatic cancer. The drugs, known as incretin mimetic drugs include drugs such as  Byetta and Bydureon (exenatide); Victoza (liraglutide); Januvia, Janumet, Janumet XR, and Juvisync (sitagliptin); Onglyza and Kombiglyze XR (saxagliptin); Nesina, Kazano, and Oseni (alogliptin); and Tradjenta and Jentadueto […]

type-2-diabetes-associated-pancreatic-cancerSome Type 2 diabetes drugs are being associated with potential increased risks for pancreatitis and pancreatic cancer. The drugs, known as incretin mimetic drugs include drugs such as  Byetta and Bydureon (exenatide); Victoza (liraglutide); Januvia, Janumet, Janumet XR, and Juvisync (sitagliptin); Onglyza and Kombiglyze XR (saxagliptin); Nesina, Kazano, and Oseni (alogliptin); and Tradjenta and Jentadueto (linagliptin).

In a just-released U.S. Food and Drug Administration (FDA) Drug Safety Communication, the agency said it is investigating reports of potential increased risks of pancreatitis and pre-pancreatic cancer findings associated with these medications. The research includes some unpublished new findings, which suggests an increased risk of pancreatitis, or inflammation of the pancreas, and pre-cancerous cellular changes—pancreatic duct metaplasia—in Type 2 diabetic patients treated with incretin mimetics.

Prior research also revealed that Januvia and Byetta have been associated with reports of increased risks for pancreatic and thyroid cancers. A new study also found that the drugs may double patients’ risks for developing pancreatitis, the first time a study put a number to the risk.

Incretin Mimetic Drugs

Incretin mimetic drugs imitate the body’s incretin hormones. These hormones are meant to stimulate insulin release following consumption of meals and are typically used in collaboration with diet and exercise to lower blood sugar in adults diagnosed with Type 2 diabetes. In 2009, the agency required a label update on these drugs warning of the risk of acute pancreatitis, a painful, potentially fatal disorder and a known risk factor for pancreatic cancer.

The drugs increase certain natural substances that lower raised blood sugar levels. Diabetics typically have abnormally low amount insulin levels or their bodies have difficulties utilizing insulin efficiently.

In the United States, about 8.6 percent of the population—25 million people—were diagnosed with diabetes in 2010, based on prior Bloomberg.com data. That number is expected to rise to more than 34 million by 2020.

Pancreatitis, Pancreatic Cancer

Pancreatitis is an inflammation of the pancreas that is linked to cancer and kidney failure. Chronic pancreatitis is painful, potentially fatal, and a known risk factor for pancreatic cancer.

Other serious side effects have been linked to these Type 2 diabetes drugs including:

  • Low blood sugar
  • Anaphylaxis and other allergic reactions, such as hives, rash, swelling of the face, lips, tongue, and/or throat
  • Diseases of the pancreas such as acute, necrotizing, or heomorrhagic pancreatitis; pancreatic cancer
  • Thyroid cancer
  • Nausea
  • Vomiting
  • Anorexia
  • Persistent, severe abdominal pain, sometimes radiating to the back
  • Death.

Although the FDA said it has not reached any new conclusions about the safety risks associated incretin mimetics, the agency informed the public and the health care community that it intends to secure and evaluate the new research that reveals links between these Type 2 medications and increased risks for pancreatic diseases, including cancer of the pancreas.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
Ms christina morace was wonderful, she answered all my questions and concerns
Anita Grayson
2 years ago
5 Star Reviews 150
It was so easy working with PW, I was kept informed about everything. I was very please with the service.
Joseph Saberito
4 months ago
5 Star Reviews 150
Positive: Professionalism , Quality , Responsiveness , Value
David Gillis Jr
3 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038